Core Insights - The pharmaceutical giant is optimistic about its future, indicating strong positioning beyond the next decade due to increased expectations for its key drugs [1] Summary by Categories - **Company Outlook** - The company expresses confidence in its long-term prospects, suggesting that it is well-prepared for growth beyond the next ten years [1] - **Key Drug Performance** - There is an emphasis on higher expectations for the company's key drugs, which are expected to drive future revenue and growth [1]

Core Insights - The drugmaker reported a third-quarter profit of $3.93 billion, driven by increased sales of key drugs which helped to mitigate the impact of patent expirations [1] Financial Performance - The third-quarter profit reached $3.93 billion, indicating strong financial performance despite challenges [1] - Higher sales for key drugs were a significant factor contributing to the profit [1] Market Impact - The company successfully offset losses from patent expirations through strategic sales increases [1]